Nordstrum v. Mylan, Inc. <b><font color="red"> REMINDER TO COUNSEL -- This case is a tag-a-long action to 17-md-2785, MDL 2785 In Re: Epipen (Epinepherine Injection USP) Marketing, Sales Practices and Antitrust Litigation.</font></b>
Federal class action docket 2:17-cv-02451 in KSD.
This is a court docket record, not a settlement. The Federal Judicial Center marked this case as a class action. A closed docket does not tell us whether it settled, was dismissed, or ended another way — and there is no claim to file here. Browse settlements accepting claims →
Case facts
- Court
- KSD
- Docket number
- 2:17-cv-02451
- Filed
- August 8, 2017
- Docket closed
- July 12, 2022
- Time on the docket
- 4.9 years
- Presiding judge
- Judge Daniel D. Crabtree
- Referred to
- Magistrate Teresa J. James
- Jurisdiction
- Federal Question
- Jury demand
- Plaintiff
- Last docket activity
- July 12, 2022
- Nature of suit
- 410 Anti-Trust
What the case was brought under
The docket records the cause of action as 15:1 Antitrust Litigation. Price fixing, market allocation, monopolisation and other claims that competition was suppressed to the class's cost.
The full court record
ClaimWatch publishes the docket metadata above from public bulk data. The filings themselves — complaints, orders, and any settlement agreement — live on CourtListener.
View the full docket on CourtListener →More antitrust class actions in the archive, or search all 45,794 cases.